1. Yao Ming Helian, Wuxi, Jiangsu Province: focuses on providing end-to-end CRDMO services for antibody-coupled drugs (ADC), covering the R&D and production fields of antibody intermediates and other coupled biopharmaceuticals, connectors/chemical payloads, coupling stock solutions and preparations.
2. Changzhou Hequan Company: It is a pharmaceutical manufacturing industry, and its business scope includes the development, consultation, service and transfer of biotechnology, new compound drugs, active ingredient drugs, chemical raw materials and drug compound technologies.